Search results for "Newborn screening"

showing 10 items of 16 documents

International working group identifies need for newborn screening for mucopolysaccharidosis type I but states that existing hurdles must be overcome

2018

Abstract Aim Mucopolysaccharidosis type I is a lysosomal storage disorder that can result in significant disease burden, disability and premature death, if left untreated. The aim of this review was to elaborate on the diagnosis of mucopolysaccharidosis type I and the pros and cons of newborn screening. Methods An international working group was established to discuss ways to improve the early diagnosis of mucopolysaccharidosis type I. It consisted of 13 experts in paediatrics, rare diseases and inherited metabolic diseases from Europe and the Middle East. Results It is becoming increasingly clearer that the delay between symptom onset and clinical diagnosis is considerable for mucopolysacc…

0301 basic medicinemedicine.medical_specialtyHaematopoietic stem cell transplantLysosomal storage disorderMucopolysaccharidosis ILysosomal storage disordersReview ArticleDisease03 medical and health sciencesMucopolysaccharidosis type INeonatal Screening0302 clinical medicinemedicineHumansLaronidasePediatrics Perinatology and Child HealthIntensive care medicineReview ArticlesDisease burdenNewborn screeningbusiness.industryMucopolysaccharidosis type IInfant NewbornGeneral MedicineEnzyme replacement therapyInternational working group030104 developmental biologyEnzyme replacement therapyClinical diagnosisPediatrics Perinatology and Child Healthbusiness030217 neurology & neurosurgeryActa Paediatrica
researchProduct

Immigration and changes in the epidemiology of hemoglobin disorders in Italy : an emerging public health burden

2012

Abstract Background In the last years Italy is confronting with massive migratory movements from developing countries where hemoglobinopathies are widespread. This is causing a large diffusion and a changing spectrum in the epidemiology of hemoglobin disorders in Italy. Methods Investigations recently published in Italy on hemoglobinopathies among immigrants were revised in order to appreciate the impact of immigration from developing countries on epidemiology of these pathologies and to outline adequate guidelines of prevention. Results Although in Italy there is a limited number of investigations regarding the relation between immigration and hemoglobin disorders, published data show that…

CounselingMalePediatricsmedicine.medical_specialtymedia_common.quotation_subjectImmigrationMEDLINEDeveloping countryImmigrationReviewNeonatal ScreeningPregnancyEnvironmental healthEpidemiologymedicineHumansmedia_commonNewborn screeningPregnancybusiness.industryPublic healthInfant Newbornlcsh:RJ1-570lcsh:PediatricsEmigration and Immigrationmedicine.diseaseHemoglobinopathiesHemoglobin disordersItalyFemalePublic HealthbusinessItalian Journal of Pediatrics
researchProduct

A Multicentre Pilot Study of a Two-Tier Newborn Sickle Cell Disease Screening Procedure with a First Tier Based on a Fully Automated MALDI-TOF MS Pla…

2019

The reference methods used for sickle cell disease (SCD) screening usually include two analytical steps: a first tier for differentiating haemoglobin S (HbS) heterozygotes, HbS homozygotes and β-thalassemia from other samples, and a confirmatory second tier. Here, we evaluated a first-tier approach based on a fully automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) platform with automated sample processing, a laboratory information management system and NeoSickle® software for automatic data interpretation. A total of 6701 samples (with high proportions of phenotypes homozygous (FS) or heterozygous (FAS) for the inherited genes for sickle h…

MALDI-TOFPediatricsmedicine.medical_specialtythalassemia[SDV]Life Sciences [q-bio]Sample (statistics)01 natural sciencesArticle03 medical and health sciencesImmunology and Microbiology (miscellaneous)preventionmedicineDisease Screening Procedure030304 developmental biologymass spectrometry0303 health sciencesNewborn screeningbusiness.industryMALDI-TOF; sickle cell disease; newborn screening; mass spectrometry; thalassemia; preventionnewborn screening010401 analytical chemistrylcsh:RJ1-570Obstetrics and GynecologyData interpretationlcsh:Pediatrics0104 chemical sciencesMatrix-assisted laser desorption/ionizationFully automatedSickle haemoglobinPediatrics Perinatology and Child Healthsickle cell diseaseSample collectionbusinessInternational Journal of Neonatal Screening
researchProduct

Newborn screening and disease variants predict neurological outcome in isovaleric aciduria.

2021

Isovaleric aciduria (IVA), a metabolic disease with severe (classic IVA) or attenuated phenotype (mild IVA), is included in newborn screening (NBS) programs worldwide. The long-term clinical benefit of screened individuals, however, is still rarely investigated. A national, prospective, observational, multi-center study of individuals with confirmed IVA identified by NBS between 1998 and 2018 was conducted. Long-term clinical outcomes of 94 individuals with IVA were evaluated, representing 73.4% (for classic IVA: 92.3%) of the German NBS cohort. In classic IVA (N = 24), NBS prevented untimely death except in one individual with lethal neonatal sepsis (3.8%) but did not completely prevent si…

MalePediatricsmedicine.medical_specialtyAdolescentNeurocognitive DisordersDisease03 medical and health sciencesYoung AdultCognitionNeonatal ScreeningMaintenance therapyGermanyGeneticsmedicineHumansProspective StudiesMetabolic diseaseChildAmino Acid Metabolism Inborn ErrorsGenetics (clinical)030304 developmental biology0303 health sciencesNewborn screeningNeonatal sepsisIsovaleryl-CoA Dehydrogenasebusiness.industry030305 genetics & heredityInfant NewbornInfantmedicine.diseasePrognosisIsovaleric AcidemiaPhenotypeChild PreschoolCohortFemalesense organsbusinessNeurocognitiveJournal of inherited metabolic diseaseREFERENCES
researchProduct

Two novel mutations in the human thyroid peroxidase (TPO) gene: genetics and clinical findings in four children

2009

UNLABELLED We report four children originating from two unrelated German families with congenital hypothyroidism (CH) due to mutations in the thyroid peroxidase (TPO) gene. Three female siblings (family 1) were found to be compound heterozygous for two mutations, a known mutation in exon 9 (W527C), and a mutation in exon 8 (Q446H), which has not been described before. In the second family we identified a boy with goitrous CH, who had a novel homozygous mutation in the TPO gene in exon 16 (W873X). All children of family 1 were diagnosed postnatally by newborn screening. The case of the boy of family 2 has already been reported for the in utero treatment of a goiter with hypothyroidism. CONCL…

Maleendocrine systemmedicine.medical_specialtyMutation MissenseThyrotropinGene mutationCompound heterozygositymedicine.disease_causeIodide PeroxidaseUltrasonography PrenatalExonChild DevelopmentThyroid peroxidaseInternal medicineCongenital HypothyroidismmedicineHumansMissense mutationGeneticsMutationNewborn screeningbiologybusiness.industryInfant NewbornInfantGeneral MedicineFetal Bloodmedicine.diseaseCongenital hypothyroidismEndocrinologyCodon NonsenseChild PreschoolPediatrics Perinatology and Child Healthbiology.proteinFemalebusinessActa Paediatrica
researchProduct

A novel mutation in the PAX8 promoter region causes permanent congenital hypothyroidism in a patient with Down’s Syndrome

2014

Thyroid dysfunction is common in newborn infants with Down’s syndrome (DS) but defects in organogenesis have not been described. A female infant was diagnosed to have trisomy 21, atrio-ventricular septal defect and patent ductus. Newborn screening showed capillary TSH 43.8 mU/L(day 5), venous TSH >150 mU/l and free T4 15.1 pmol/L (day 12). Thyroid ultrasound showed a small gland with heterogenous echotexture and cystic changes. Scintigraphy showed normal uptake into an eutopic gland. The infant was treated with thyroxine and underwent cardiac repair at 69 days. Sequencing analysis of candidate genes involved in thyroid development revealed a new heterozygous mutation close to the transcript…

Newborn screeningCandidate genemedicine.medical_specialtybusiness.industryThyroidMutantPromotermedicine.diseaseCongenital hypothyroidismmedicine.anatomical_structureEndocrinologyInternal medicineMeeting AbstractmedicinePAX8businessTrisomyMolecular and Cellular Pediatrics
researchProduct

Survey of Italian pediatricians’ perspectives and knowledge about neonatal screening

2015

Background The goal of newborn screening is early identification of babies with a high risk for disorders that may not be clinically evident at birth, but have severe consequences if untreated. New insight into inherited diseases and the ability to test for numerous diseases using new technique such as tandem mass spectrometry have made it practical to greatly expand the number of conditions tested. The expanded neonatal screening is now available and relatively simple, but this represents only a part of the picture. Positive results require follow-up confirmation. Most disorders screened require confirmatory biochemical or genetic tests and specialist visits. An efficient system is needed …

Newborn screeningHealth Knowledge Attitudes PracticePediatricsmedicine.medical_specialtyPRIMARY CONTACTMEDLINEHealth knowledgePediatricsInfant Newborn DiseasesExpanded newborn screeningNeonatal ScreeningExpanded newborn screening; Newborn screening; Pediatricians; Survey; Pediatrics Perinatology and Child HealthTandem Mass SpectrometryPediatricianHumansMedicinePediatriciansSurveyIntensive care medicineNewborn screeningbusiness.industryMaternal and child healthResearchInfant NewbornItalyPediatrics Perinatology and Child HealthbusinessItalian Journal of Pediatrics
researchProduct

Keypoints to Successful Newborn Hearing Screening. Thirty Years of Experience and Innovations

2021

Congenital deafness is a major pediatric problem, affecting about 1.5–3 per 1000 newborns. The early treatment through cochlear implantation and auditory rehabilitation has been a historic milestone. Early diagnosis of congenital deafness is an essential requirement to obtain the best results, which is achieved through neonatal screening, a diagnostic practice that we began systematically at the Hospital Clínico in Valencia (Spain) 30 years ago. Neonatal hearing screening is successful in most developed countries. Its implementation has been slow due to the multiple difficulties that its universal application entails since it involves several health professionals and must be carried out, in…

Newborn screeningHealth professionalsnewborn screeningLeadership and Managementbusiness.industryHealth PolicyRAuditory rehabilitationHealth InformaticsReviewotoacoustic emissionsmedicine.diseaseneonatal hearing screeningHearing screeningHealth Information ManagementdeafnessMilestone (project management)MedicineMedicineMedical emergencybusinessCochlear implantationDeveloped countryHealthcare
researchProduct

Maternal vitamin deficiency mimicking multiple acyl-CoA dehydrogenase deficiency on newborn screening

2021

Abstract Background In infancy multiple acyl-CoA dehydrogenase deficiency (MADD) is commonly a severe inherited metabolic disease caused by genetic defects in electron transfer flavoprotein (ETF) or ETF ubiquinone oxidoreductase. Both enzymes require flavin adenine dinucleotide (FAD) as a cofactor. Riboflavin (vitamin B2) is a precursor in the synthesis of FAD. MADD can be detected by newborn screening (NBS) based on elevation of multiple acylcarnitines. Methods We present the results of two children whose NBS results and subsequent confirmatory testing resulted in a suspected diagnosis of MADD. In parallel in both children vitamin B12 deficiency was detected. Results Biochemical profiles n…

Newborn screeningMedicine (General)medicine.medical_specialtyQH301-705.5FlavoproteinRiboflavinMaternalCofactorchemistry.chemical_compoundR5-920EndocrinologyMultiple acyl-CoA dehydrogenase deficiencyInternal medicineGeneticsmedicineVitamin B12Biology (General)Multiple Acyl-CoA Dehydrogenase DeficiencyMother and child healthMolecular Biologychemistry.chemical_classificationFlavin adenine dinucleotideNewborn screeningbiologybusiness.industryfood and beveragesEnzymeEndocrinologyVitamin B12 deficiencychemistrybiology.proteinbusinessResearch PaperMolecular Genetics and Metabolism Reports
researchProduct

Preliminary clinical efficacy and safety of BMN 701, GILT-tagged recombinant human acid alpha glucosidase (rhGAA), in late-onset Pompe disease: resul…

2014

Metachromatic leukodystrophy (MLD) is a lysosomal disorder that results from the deficiency of the lysosomal enzyme arylsulfatase A. It is characterized by motor and developmental regression, seizures, deafness, blindness, dementia and premature death. There are three types of onsets: late infantile, juvenile, and adult. We performed a retrospective chart review of 71 patients (47 infantile, 23 juvenile) evaluated at the Program for Study of Neurodevelopment in Rare Disorders (NDRD) between January 2000 and August 2013. The patients were evaluated prospectively using a standardized protocol. The purpose of the study is to describe the natural course of the disease. In 31 patients only a bas…

Newborn screeningPediatricsmedicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismLate onsetDiseasemedicine.diseaseBiochemistryVirologyMetachromatic leukodystrophyEndocrinologyGeneticsmedicineDementiaJuvenileAge of onsetbusinessMolecular BiologyDevelopmental regressionMolecular Genetics and Metabolism
researchProduct